Home Alexion gets EU approval for drug acquired in Synageva deal
 

Keywords :   


Alexion gets EU approval for drug acquired in Synageva deal

2015-09-02 03:25:24| Biotech - Topix.net

Ten weeks after closing its $8.4 billion purchase of Synageva BioPharma Corp, Alexion Pharmaceuticals Inc on Tuesday announced European approval for the key drug acquired through the deal, an enzyme-replacement therapy for an ultra-rare, life threatening disease. European health regulators approved Kanuma for patients with lysosomal acid lipase deficiency .

Tags: in deal drug approval

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.11STEINBACH40
24.11 Sepua Crue F-170
24.11 SECRET
24.11CRAwith
24.1111/15)&&
24.11 8
24.11
24.11F2023 23
More »